No recourse for privately insured

People with employer-paid health insurance cannot seek compensation for malpractice should they experience problems with treatment.

The revelation comes after woman on Funen had her request for compensation rejected on the grounds that the treatment she was complaining over had been paid for by her employer, in this case a local council.

The woman is now seeking to have that decision overturned in court. The outcome could have a wide-ranging impact.

During the 2000s, large numbers of people signed up for private health insurance through their employers as a form of benefit. One insurance company, Falck Healthcare, has agreements with 3,000 firms. 

Jyllands- Posten

SEE RELATED: Size a factor in maternity ward complaints

 

Interested in receiving stories like these delivered to your inbox by 8am each weekday? Sign up for the Morning Briefing or any of our other newsletters today.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.